Difference between revisions of "NCCN guidelines"
Jump to navigation
Jump to search
m (→Fatigue) |
|||
(6 intermediate revisions by the same user not shown) | |||
Line 3: | Line 3: | ||
'''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.''' | '''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.''' | ||
=Guidelines= | =Guidelines= | ||
+ | ==AYA== | ||
+ | *[https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1412 NCCN Guidelines - Adolescent and Young Adult (AYA) Oncology] | ||
==Bone Health== | ==Bone Health== | ||
*'''2009:''' Gralow et al. [https://doi.org/10.6004/Jnccn.2009.0076 NCCN Task Force Report: Bone Health in Cancer Care.] [https://pubmed.ncbi.nlm.nih.gov/19555589/ PubMed] | *'''2009:''' Gralow et al. [https://doi.org/10.6004/Jnccn.2009.0076 NCCN Task Force Report: Bone Health in Cancer Care.] [https://pubmed.ncbi.nlm.nih.gov/19555589/ PubMed] | ||
==Cancer Screening== | ==Cancer Screening== | ||
− | *'''2018:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2018.0083 Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/30442736/ PubMed] | + | *[https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1421 NCCN Guidelines - Breast Cancer Screening and Diagnosis] |
− | *''' | + | **'''2018:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2018.0083 Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/30442736/ PubMed] |
− | *''' | + | **'''2009:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2009.0070 NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.] [https://pubmed.ncbi.nlm.nih.gov/19930975/ PubMed] |
− | *''' | + | **'''2003:''' Authors not listed. [https://doi.org/10.6004/Jnccn.2003.0023 Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/19768883/ PubMed] |
− | *''' | + | *[https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1429 NCCN Guidelines - Colorectal Cancer Screening] |
+ | **'''2016:''' Williams et al. [https://doi.org/10.6004/Jnccn.2016.0154 Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening.] [https://pubmed.ncbi.nlm.nih.gov/27799515/ PubMed] | ||
+ | **'''2010:''' Burt et al. [https://doi.org/10.6004/Jnccn.2010.0003 NCCN clinical practice guidelines in oncology. Colorectal cancer screening.] [https://pubmed.ncbi.nlm.nih.gov/20064289/ PubMed] | ||
==Cancer Related Infections== | ==Cancer Related Infections== | ||
Line 20: | Line 24: | ||
==Cancer Risk Reduction== | ==Cancer Risk Reduction== | ||
*'''2016:''' Shields et al. [https://doi.org/10.6004/Jnccn.2016.0152 Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/27799513/ PubMed] | *'''2016:''' Shields et al. [https://doi.org/10.6004/Jnccn.2016.0152 Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/27799513/ PubMed] | ||
− | *'''2015:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2015.0105 Breast Cancer Risk Reduction, Version 2.2015.] [https://pubmed.ncbi.nlm.nih.gov/26150582/ PubMed] | + | *[https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1420 NCCN Guidelines - Breast Cancer Risk Reduction] |
− | *'''2003:''' Authors not listed. [https://doi.org/10.6004/Jnccn.2003.0026 Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/19768886/ PubMed] | + | **'''2015:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2015.0105 Breast Cancer Risk Reduction, Version 2.2015.] [https://pubmed.ncbi.nlm.nih.gov/26150582/ PubMed] |
+ | **'''2003:''' Authors not listed. [https://doi.org/10.6004/Jnccn.2003.0026 Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/19768886/ PubMed] | ||
+ | |||
+ | ==Distress Managtement== | ||
+ | *[https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1431 NCCN Guidelines - Distress Management] | ||
==Geriatric Oncology== | ==Geriatric Oncology== | ||
*'''2012:''' Hurria et al. [https://doi.org/10.6004/Jnccn.2012.0019 Senior adult oncology.] [https://pubmed.ncbi.nlm.nih.gov/22308515/ PubMed] | *'''2012:''' Hurria et al. [https://doi.org/10.6004/Jnccn.2012.0019 Senior adult oncology.] [https://pubmed.ncbi.nlm.nih.gov/22308515/ PubMed] | ||
− | *'''2005:''' Balducci et al. [https://doi.org/10.6004/Jnccn.2005.0032 Senior adult oncology clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/16038647/ PubMed] | + | **'''2005:''' Balducci et al. [https://doi.org/10.6004/Jnccn.2005.0032 Senior adult oncology clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/16038647/ PubMed] |
==Middle East and North Africa== | ==Middle East and North Africa== | ||
Line 56: | Line 64: | ||
==Fatigue== | ==Fatigue== | ||
− | *'''2010:''' Berger et al. [https://doi.org/10.6004/Jnccn.2010.0067 NCCN Clinical Practice Guidelines Cancer-related fatigue.] [https://pubmed.ncbi.nlm.nih.gov/20870636/ PubMed] | + | *[https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1424 NCCN Guidelines - Cancer-Related Fatigue] |
+ | **'''2010:''' Berger et al. [https://doi.org/10.6004/Jnccn.2010.0067 NCCN Clinical Practice Guidelines Cancer-related fatigue.] [https://pubmed.ncbi.nlm.nih.gov/20870636/ PubMed] | ||
[[Category:Guideline pages]] | [[Category:Guideline pages]] |
Latest revision as of 11:27, 7 May 2024
This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page.
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.
Guidelines
AYA
Bone Health
- 2009: Gralow et al. NCCN Task Force Report: Bone Health in Cancer Care. PubMed
Cancer Screening
- NCCN Guidelines - Breast Cancer Screening and Diagnosis
- 2018: Bevers et al. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. PubMed
- 2009: Bevers et al. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. PubMed
- 2003: Authors not listed. Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology. PubMed
- NCCN Guidelines - Colorectal Cancer Screening
Cancer Related Infections
- 2016: Baden et al. Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. PubMed
- 2012: Baden et al. Prevention and treatment of cancer-related infections. PubMed
- 2008: Segal et al. Prevention and treatment of cancer-related infections. PubMed
Cancer Risk Reduction
- 2016: Shields et al. Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. PubMed
- NCCN Guidelines - Breast Cancer Risk Reduction
- 2015: Bevers et al. Breast Cancer Risk Reduction, Version 2.2015. PubMed
- 2003: Authors not listed. Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology. PubMed
Distress Managtement
Geriatric Oncology
- 2012: Hurria et al. Senior adult oncology. PubMed
- 2005: Balducci et al. Senior adult oncology clinical practice guidelines in oncology. PubMed
Middle East and North Africa
- 2010: Abulkhair et al. Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region. PubMed
- 2010: Içli et al. Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region. PubMed
- 2010: Yusuf et al. Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region. PubMed
- 2010: Bazarbachi et al. Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region. PubMed
- 2010: Jazieh et al. Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region. PubMed
- 2010: Shamieh et al. Modification and implementation of NCCN Guidelines on palliative care in the Middle East and North Africa region. PubMed
- 2010: Hassen et al. Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region. PubMed
Myeloid Growth Factor
- 2013: Crawford et al. Myeloid growth factors. PubMed
- 2011: Crawford et al. Myeloid growth factors. PubMed
- 2009: Crawford et al. Myeloid growth factors. PubMed
- 2007: Crawford et al. Myeloid growth factors. Clinical practice guidelines in oncology. PubMed
- 2005: Crawford et al. Myeloid growth factors clinical practice guidelines in oncology. PubMed
Palliative Care
- 2009: Levy et al. NCCN clinical practice guidelines in oncology: palliative care. PubMed
Survivorship
- 2017: Denlinger et al. Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. PubMed
- 2014: Denlinger et al. Survivorship: healthy lifestyles, version 2.2014. PubMed
- 2014: Denlinger et al. Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology. PubMed
- 2014: Denlinger et al. Survivorship: pain version 1.2014. PubMed
- 2014: Denlinger et al. Survivorship: sexual dysfunction (female), version 1.2013. PubMed
- 2014: Denlinger et al. Survivorship: sexual dysfunction (male), version 1.2013. PubMed
- 2014: Denlinger et al. Survivorship: sleep disorders, version 1.2014. PubMed